Imaging Immune Therapies in Brain Tumor PatientsQ&A with Samuel Cheshier, M.D., Ph.D.
Brain tumors are the most common type of cancer occurring in children aged 14 and younger—as well as the leading cause of cancer death in that age group. Pediatric neurosurgeon Samuel Cheshier is working on new technologies to improve immunotherapy treatments and track their effectiveness over time.
What is “Hope” for a Patient with a Deadly Brain Tumor?
The Brain Tumor Center at Duke University is known for its aggressive approach to treating brain tumors in patients who have, at best, a 10-15 percent chance of survival. Some of the strategies: initiating more clinical trials than virtually any other tumor treatment center in the world, using drugs “off label,” and performing operations many surgeons will not attempt. Friedman talks about the center’s approach, the ethical issues, and the impact on patients and families.